EPA-0790 – All-cause discontinuation and safety of aripiprazole once-monthly for the treatment of schizophrenia: A pooled analysis of two double-blind, randomized, controlled trials
- Resource Type
- Abstract
- Source
- In
European Psychiatry 2014 29 Supplement 1:1-1 - Subject
- Language
- ISSN
- 0924-9338